{"ticker": {"uuid": "ae65e54f-68fd-49d4-bb5e-0f45bbfd0c6e", "symbol": "RCEL", "name": "Avita Medical Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "AVITA Medical to announce Q2 2026 financial results on August 6", "summary": "AVITA Medical has announced that it will release its second-quarter 2026 financial results after the U.S. financial markets close on August 6, 2026. The company will also host a conference call and webcast on the same day to discuss its financial performance and recent business h", "url": "https://scanx.trade/stock-market-news/companies/avita-medical-to-announce-q2-2026-financial-results-on-august-6/45616032", "source_name": "scanx.trade", "published_at": "2026-07-14T23:42:29", "published_display": "14 Jul 2026 23:42", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Schedules Q2 Results Call for Aug. 6 Webcast", "summary": "AVITA Medical (NASDAQ: RCEL, ASX: AVH) announced it will release its second quarter 2026 financial results after the close of U.S. financial markets on Thursday, August 6, 2026. The company will host a conference call and webcast at 1:30 p.m. Pacific Time the same day to discuss ", "url": "https://www.stocktitan.net/news/RCEL/avita-medical-to-announce-second-quarter-2026-financial-dewd7wgzl9j0.html", "source_name": "Stock Titan", "published_at": "2026-07-14T19:41:52", "published_display": "14 Jul 2026 19:41", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical to Announce Second Quarter 2026 Financial Results", "summary": "AVITA Medical, a therapeutic acute wound care company, announced it will release its second quarter 2026 financial results after the U.S. financial markets close on Thursday, August 6, 2026. The company will host a conference call and webcast on the same day at 1:30 p.m. Pacific ", "url": "https://ca.finance.yahoo.com/news/avita-medical-announce-second-quarter-200500002.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-14T19:41:52", "published_display": "14 Jul 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical (RCEL) Stock Sees Fair Value Lift As Analysts Back RECELL Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQWlVSdDhzMWRKWlZaRldpY1B0MEpZWlhCZTZwQTNkRlgzVlEzdEN6c2FrYldabjhhXzU2ZThta3ZYQlAxdjUxNVVoX0t0UjhsTm5nanAxZHRWdHZFVXNnZUVLbG1La0h4TFU0QnZQSWZWMjJKbDhYR3NGWHdsMkxYZWY4dm42ZFd0RGNfcy1uSHZxelJoSTZIU3JR?oc=5", "source_name": "Market source", "published_at": "2026-07-14T16:14:17+00:00", "published_display": "14 Jul 2026 16:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RCEL: Renewed Adoption Confidence Will Support Future Bullish Repricing", "summary": "Analysts have raised their consolidated price target for AVITA Medical (RCEL) to $12, citing renewed confidence in RECELL adoption, organic revenue momentum, and sufficient working capital. While bullish, some analysts acknowledge potential risks if RECELL uptake slows or executi", "url": "https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-rcel/avita-medical/ybvdyrt6-medicare-resolution-and-trauma-expansion-will-shape-future-wound-care-yb12/updates/7-analysts-have-raised-their-consolidated-price-target-for-avi", "source_name": "Simply Wall Street", "published_at": "2026-07-13T17:41:21", "published_display": "13 Jul 2026 17:41", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs \u2013 MUN:51KB", "summary": "This article provides the enterprise value to EBITDA forward for AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs, traded on the Munich Stock Exchange under the symbol MUN:51KB. The information is presented within a financial overview provided by TradingView, detaili", "url": "https://www.tradingview.com/symbols/MUN-51KB/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-12T17:09:38", "published_display": "12 Jul 2026 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical(RCEL) Stock Options Chain | Quotes & News", "summary": "This article provides details on Avita Medical's (RCEL) stock options chain, offering quotes and news related to the company's financial instruments. It serves as a resource for investors interested in RCEL's options performance and market activities.", "url": "https://www.moomoo.com/stock/RCEL-US/options-chain?chain_id=Name1K9-3FXPhg.1l07fo0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A57,%22f%22%3A%22www.moomoo.com%2Fstock%2F5026-BMS%2Fnews%22%7D", "source_name": "Moomoo", "published_at": "2026-07-04T07:09:43", "published_display": "04 Jul 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical (RCEL) Upgraded to Buy: Here's Why", "summary": "Avita Medical (RCEL) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in its earnings estimates. The Zacks rating system highlights the strong correlation between revisions in earnings estimates and near-term stock price movements, making this upgrade a positive ", "url": "https://ca.finance.yahoo.com/news/avita-medical-rcel-upgraded-buy-160003407.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-03T16:09:15", "published_display": "03 Jul 2026 16:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical Downgraded to Hold From Speculative Buy by Morgans", "summary": "Morgans has downgraded Avita Medical (ASX:AVH) from a \"Speculative Buy\" to a \"Hold\" rating. This change reflects a revised outlook from the analyst following a recent assessment of the company. Investors should consider this updated rating in their evaluation of Avita Medical's s", "url": "https://www.moomoo.com/news/post/72420522/avita-medical-downgraded-to-hold-from-speculative-buy-by-morgans?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-03T06:09:59", "published_display": "03 Jul 2026 06:09", "sentiment": "negative", "sentiment_pct": 29, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs \u2013 ASX:AVH", "summary": "This page from TradingView displays the \"Price to sales forward\" financial metric for AVITA Medical Inc Shs Chess Depository Interests, traded on the Australian Securities Exchange under the ticker ASX:AVH. The article provides a high-level overview of the company's financial dat", "url": "https://www.tradingview.com/symbols/ASX-AVH/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T02:39:41", "published_display": "30 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000 Index", "summary": "AVITA Medical, Inc. (NasdaqCM: RCEL) has been removed from the Russell 3000 Index, along with several other Russell indices including the Russell Small Cap Comp Growth Benchmark, Russell 2500 Growth Benchmark, and Russell 2000 Dynamic Index. This news was published on June 29, 20", "url": "https://www.marketscreener.com/news/avita-medical-inc-nasdaqcm-rcel-dropped-from-russell-3000-index-ce7f5fdeda8df027", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T12:47:00", "published_display": "29 Jun 2026 12:47", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Avita Medical, Inc. \u2013 NASDAQ:RCEL", "summary": "This article focuses on the enterprise value to EBITDA forward for Avita Medical, Inc. (NASDAQ: RCEL). It seems to be a financial data point from TradingView, indicating a specific valuation metric for the company. The content primarily presents navigation and various data source", "url": "https://www.tradingview.com/symbols/NASDAQ-RCEL/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T18:40:20", "published_display": "28 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical", "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AVITA Medical, Inc. (NASDAQ:RCEL) after the company's stock fell 25.8% following the announcement of its CEO's immediate departure. Investors who purchased AVITA securities are encoura", "url": "https://natlawreview.com/press-releases/bronstein-gewirtz-grossman-llc-investigating-avita-medical-inc-rcel-and", "source_name": "The National Law Review", "published_at": "2026-06-28T17:09:40", "published_display": "28 Jun 2026 17:09", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000 Growth Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOZzBzSWRwSzVoazNRMVpzZzNIWTY2Z19WTzc5ckxscUNHcGhNR2M3OVBZVE93UG5WdVpUeWh2QUJHeEF6SFZNcWhZQWs2bXhqTTU0UXlRVktmWmgxU2lpMW9hVGNxU2tvV0RHMkkwVWNqcjVkTG1GSWxGOVhEMVd6N29YdWMxOXNVT0RNRzBWTjhDcS0yQ0dVS0JRTHJIR2RGTVZkNFZqNUFXNHVWRG1MRHJ1SnlYX21oaWs0MVlWRnltMFk4U3c?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of AVITA Medical Inc \u2013 LS:A2P733", "summary": "This article provides financial information for AVITA Medical Inc (LS:A2P733) on TradingView, specifically focusing on its forward price-to-book ratio. The content is brief, indicating that the market was closed at the time of viewing and no trades were recorded for the stock.", "url": "https://www.tradingview.com/symbols/LS-A2P733/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T11:40:11", "published_display": "26 Jun 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Avita Medical, Inc. \u2013 NASDAQ:RCEL", "summary": "This article provides financial information for Avita Medical, Inc. (NASDAQ: RCEL), specifically focusing on its forward price-to-sales ratio. It presents a simple table with the period, value, change, and percentage change for this metric, noting that the data is sourced from Fa", "url": "https://www.tradingview.com/symbols/NASDAQ-RCEL/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T19:39:49", "published_display": "25 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3VmWDdGZC04R2RXUUJZTHJqVlJrdnhJYy1LaEJkcHBaWi1sWXdoWS1oLWFlVUQxdFNOQlNDdzhaTHJtMGRkX3pHc1pWbGp0bENwY1h6TlpvWVRWWmJxODh4emhGVDBFajd0VWNmUGNVcnN1SDBXRG9jZFVDa2M4MGFCVFhxbGN0ZXZqSTV2SUE1S3JjMTRnQlBiSnVmR0lv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG Maintains Avita Medical(RCEL.US) With Hold Rating", "summary": "BTIG has reiterated its Hold rating for Avita Medical (RCEL.US). This update indicates the firm's ongoing stance on the company's stock.", "url": "https://www.moomoo.com/news/post/71920696/btig-maintains-avita-medical-rcelus-with-hold-rating", "source_name": "Moomoo", "published_at": "2026-06-24T04:09:40", "published_display": "24 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting", "summary": "AVITA Medical presented new clinical data at the British Burn Association Annual Meeting, showcasing the first U.K. use of its RECELL GO system. A case series of 17 burn and reconstructive surgery patients at Stoke Mandeville Hospital demonstrated successful outcomes and improved", "url": "https://finance.yahoo.com/healthcare/articles/avita-medical-highlights-first-u-124000103.html", "source_name": "Market source", "published_at": "2026-06-22T04:09:40", "published_display": "22 Jun 2026 04:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical\u2019s burn treatment used in 17 U.K. patients", "summary": "AVITA Medical (NASDAQ: RCEL) announced the successful use of its RECELL GO system in 17 burn and reconstructive patients in the UK, with all patients discharged without complications and noted workflow benefits for the surgical teams. The findings were presented at the 2026 Briti", "url": "https://www.stocktitan.net/news/RCEL/avita-medical-highlights-first-u-k-clinical-experience-with-recell-ofglppe3u8op.html", "source_name": "Stock Titan", "published_at": "2026-06-19T00:09:03", "published_display": "19 Jun 2026 00:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Inc (RCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for AVITA Medical Inc (RCEL), detailing its regional revenue contributions. As of the latest update, the data primarily shows revenue by region, with the United States accounting for the vast majority. The article indicates that business ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rcel/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T11:09:38", "published_display": "17 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Inc (RCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides historical dividend and stock split information for AVITA Medical Inc (RCEL). It indicates that AVITA Medical Inc has not distributed any dividends over the past five years and shows no data for stock splits. The page primarily serves as a financial data por", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rcel/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T11:09:38", "published_display": "17 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Inc (RCEL) Financial Health: Profitability & Balance Sheet Analysis", "summary": "AVITA Medical Inc (RCEL) has a current financial score of 7.84, placing it 77th out of 388 in the Biotechnology & Medical Research industry, indicating weak financial status but high operating efficiency. The company reported a quarterly revenue of $19.25M, a 3.98% year-over-year", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rcel/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T10:09:38", "published_display": "17 Jun 2026 10:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Inc (RCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "AVITA Medical Inc (RCEL) has an earnings forecast score of 8.00, ranking 163rd in its industry. Analysts have set an average price target of $5.50, with a consensus \"Buy\" rating based on 5 analysts. The company's recent EPS was -$0.38 against an expectation of -$0.35, and the nex", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rcel/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T04:41:50", "published_display": "17 Jun 2026 04:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Inc (RCEL) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "AVITA Medical Inc (RCEL) has a risk assessment score of 2.77, ranking it 191 out of 388 in the Biotechnology & Medical Research industry. The company's beta value of 1.88 indicates higher volatility relative to the S&P 500. The risk assessment also details various financial metri", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rcel/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-17T04:41:50", "published_display": "17 Jun 2026 04:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical (RCEL) CFO receives 2,000-share equity grant in Form 4", "summary": "AVITA Medical's CFO, David D. O'Toole, was granted 2,000 shares of common stock at a reference value of $3.97 per share. This compensation-related award increased his directly held stake to 152,927 shares, which includes unvested Restricted Stock Units (RSUs). The transaction was", "url": "https://www.stocktitan.net/sec-filings/RCEL/form-4-avita-medical-inc-insider-trading-activity-594ecd07e425.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:29:51", "published_display": "12 Jun 2026 20:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRWNsVUM3aGV5UmJHYUowOWtNRU11RzZSalpyampRQ3ZQTlBNV05zSHo4MTJJS0JqTV92LWV3MUdXWkRIckNNZi1aeVg1TmtKNFpoS3g5dTBXRW1BZXRMWGo1SVl2NjNaQ2NSNV90V0MtMzBEQndVclZzUUVXbi1FU0lyU0FndlAwaXNfUVpOTXBEZWQtQVpmanRoU0JjLWxlakFJSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical (RCEL) director adds 5,200 shares in open-market buy", "summary": "AVITA Medical, Inc. director Woody Joseph Fralin purchased 5,200 shares of the company's common stock at $4.00 per share on June 9, 2026, increasing his direct holdings to 107,961 shares, which include unvested Restricted Stock Units (RSUs). This open-market transaction signals i", "url": "https://www.stocktitan.net/sec-filings/RCEL/form-4-avita-medical-inc-insider-trading-activity-4cfba4622195.html", "source_name": "Stock Titan", "published_at": "2026-06-11T02:11:16", "published_display": "11 Jun 2026 02:11", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical director Woody Fralin buys $20,800 in common stock", "summary": "AVITA Medical director Woody Fralin recently purchased 5,200 shares of the company's common stock for $20,800. This transaction increases his direct holdings to 107,961 shares, including unvested Restricted Stock Units. The purchase occurs as AVITA Medical's stock, despite a rece", "url": "https://www.investing.com/news/insider-trading-news/avita-medical-director-woody-fralin-buys-20800-in-common-stock-93CH-4736452", "source_name": "Investing.com", "published_at": "2026-06-11T02:11:16", "published_display": "11 Jun 2026 02:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical director Woody Fralin buys $41,900 in stock", "summary": "AVITA Medical director Woody Joseph Fralin purchased 10,000 shares of the company's common stock for a total of $41,900 on June 9, 2026. This insider transaction increases his direct ownership to 102,761 shares. The purchase occurred as the stock is considered undervalued by Inve", "url": "https://www.investing.com/news/insider-trading-news/avita-medical-director-woody-fralin-buys-41900-in-stock-93CH-4734034", "source_name": "Investing.com", "published_at": "2026-06-10T03:09:26", "published_display": "10 Jun 2026 03:09", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Joseph Woody Acquires 10,000 Shares of AVITA Med", "summary": "Joseph Woody, a Director at AVITA Medical Inc (RCEL), purchased 10,000 shares of the company on June 9, 2026, increasing his total holdings to 102,761 shares. This transaction is part of a trend of insider buying at AVITA Medical, with 11 insider buys and no sells over the past y", "url": "https://www.gurufocus.com/news/8908798/insider-buying-joseph-woody-acquires-10000-shares-of-avita-medical-inc-rcel", "source_name": "GuruFocus", "published_at": "2026-06-09T23:09:26", "published_display": "09 Jun 2026 23:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Woody Fralin buys 10,000 AVITA Medical (RCEL) shares", "summary": "AVITA Medical, Inc. director Woody Joseph Fralin reported purchasing 10,000 shares of common stock in open-market transactions, priced at $4.18 and $4.20 per share. The total value of these purchases was $41,900. These transactions were disclosed in a Form 4 SEC filing, indicatin", "url": "https://www.stocktitan.net/sec-filings/RCEL/form-4-avita-medical-inc-insider-trading-activity-d6b83523b05b.html", "source_name": "Stock Titan", "published_at": "2026-06-09T21:09:26", "published_display": "09 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Boreham\u2019s Crucible: Avita Medical \u201cback on track\u201d \u2026 this time", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOTnd3SWhqYVRDLXZXaHNsclhsRU5pRURQV2xxbk1NdXhSM1RHNUhGSHBCR2owWHJJLVhHQ3FCX3ZSRUFSSno3S2djbTBYdG43NmNhUk9hMTFhRl9GWkh6aHlaN1RKWTlWcWMwbnNreUJsdzY4Wi1fQTEtWFdLcnZmeHFGcEFBT1Bjci1OVy1wRjlmTS1FU2c?oc=5", "source_name": "Stockhead", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQV2pTUXRCTjY5SmdHMUhoekd1YmdUMW44R1VVYVlZZzh6QzB1VDZqSzJXT1RLOWpZeE16cGVfaVU3bUFsZ0g5OUkyRlpmQjUxUGw0eDAyb3oySURyM2taYm5qeWZRSzJHNmpLT3VSV3RNS3M3X2ZldWZNRGM4My1QYnNTRVI5WHRybDhfVll4OVdJTFpZUEpNdUZtRTVHVC1ORWFpanRUZmI1bTE0?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNMTBnNnM2WGg4UWl4LXNNdUdWLVozU3ptQlRZQTk2SFFsOEZTLTVlbU5tNnhSTVRXX3RYczQ5b2hCR254bS1QYmZqV2JfdVFYTEx2U0hFeW1VREwybmRDWEE3MEpSWldySDJNTHFXbWcta2tNY0cwM0hVWld5VnVOWE1zY1VNQS1wQkIyZHN5a0dRNktDdnBvaTcyY3RKa292aThMTmNGeUpUUVU1Unhr?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical to Host Investor Webinar Briefing", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/avita-medical-host-investor-webinar-220000491.html", "source_name": "GlobeNewswire", "published_at": "2026-05-17T22:00:00+00:00", "published_display": "17 May 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Two AVITA Medical investor Q&As with CEO Cary Vance on May 20\u201321", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPeHZORXpOOXRGcTRfdnNDSXlfc2JZbEpCbnJsT2dNMzFiVHRVM3N1VWR1UXplZVBiSW1MSm1QVWt0Z3ZPSHQxRXFaYUpUd3o4RTNhTGkwbkk2UFNCWjdPTDJjbWlQTVhJOE1GLTdOcXdLb3dqdmhsbnNkdTk3clJHZ3lnc293Z2dFX1Fxc0wtN3EyXzdibEJjWQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical (RCEL) Q1 Loss Of US$0.35 Per Share Tests Profitability Optimism", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQMHFsUkVqTXg5bDN0STFlZUJ2eW9YSUl6UGNpU2NSUUdUVDIyQno0MGp5OFM3dEpWRFZHZDJMS1dtMEdhTlV5cGgzZGpEdmtyVHNuZFItbUVGQUpmWWFObDJ2elRINUdqMkpmZGFRVWljS2VNNE5oUzN1dk1KZExrd0V4c1pKb2JjMUZvRS1ScVZoWVgxRlJvNk8xWnlQNTZZWUtwVDJDMVQ4Rno1ZThWVDZnanZLRnBLMFlxUmRzNHpKNVFCQXFRTHQzanozeGlDdnBsNzF4VDZhM0Q0a3BUR9IB5gFBVV95cUxQbWdfbEVjUDJNRjJzYUxxdUo5MHlnQ1pmV0NQVGZacm96d2hPbUNjMlZMcTdwVWRtSVA3RjVDaEVRbDFDT1VOc05rVDFiVWVkNXpWejgzQ0lXQldXcFltbF9ac0dCaGhVSzBFaHFHOUZSeEo0dGtjMlpzcWdrTGVEOEctRUUtVXZQRGNQd21CMmFoUHlBOVJYdFVZb0JwR2ZJYk04aU1xSUFUY21jdXJjOFhFSGRXRjdKRVU4T3V2blYyNnl1ZEdCZTZoWTgzZFNLVjViOUlQR0M4bHZXcWpfZi1LeGc1QQ?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/a361626e-c63d-3fd5-967e-32e8a43a5c73/avita-medical%2C-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-15T12:30:00+00:00", "published_display": "15 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical, Inc. Stock 12\u2011Month Price Target Raised to $6.99, Implies 60% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNdDZIWDU5YTJtOGd6VkVMRTRtZ2Myalh4UGtlWVZhSkotWExKZWVVck1YcV9wbm9qVUxOck10VGtMb2c2YnZsZjlRdFNYcDI1T25tR3BEMXY0cGo2cVFDVXZrWkdIcXExMy1uT0hod1VmS2JmYlFScndZQTRzZ0pOOUItck0tTWxOSFZYUHpIbDI0U25MTHlQSU1zbXhwMU9Vb0ZSNUdUc0wxTEtxS0VmV3daN0VocmE1MGh5SUt5NUUwdWx2a213LVhjMVZCdWxReW9GcURkQQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 80, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Inc (AVHHL) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/avita-medical-inc-avhhl-q1-050209093.html", "source_name": "GuruFocus.com", "published_at": "2026-05-15T05:02:09+00:00", "published_display": "15 May 2026 05:02", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/2b6fb4ce-847c-3ed0-9f45-8acf077beb31/avita-medical-q1-earnings.html", "source_name": "MarketBeat", "published_at": "2026-05-15T03:05:39+00:00", "published_display": "15 May 2026 03:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Q1 Loss Narrows, Revenue Rises; 2026 Revenue Guidance Reaffirmed", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/avita-medical-q1-loss-narrows-203607652.html", "source_name": "MT Newswires", "published_at": "2026-05-14T20:36:07+00:00", "published_display": "14 May 2026 20:36", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQQUR4Mk1URGlEdl9mZ2RyYzRyYXVxWFJCcUhDX05QSzNZNHIxbUxZdlJkNmxXQXhTQ3ZQa3lEVVJ4Sl9Tb2lNZmcwOF9MT3FtWU95MWxaMGNDMmQ2aXNpSm56bmIzakhhVElMTEFBYk5BRVBxeWFfUGZ0RnlSZGJ1OE1hVzdHQTN6cVhoZG9B?oc=5", "source_name": "Investing News Network", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical gains regulatory clearance for RECELL GO in Australia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPVzVtMkk2ZWNVVXhnZHFMNzJnMlRpNFd3ZkFqSFFJeEhiLUdEV2FYVGtzUFQzckVrMDVjRGtLUjJUeHNZRXQ2WFVqaTQzMEFLOTRYOElxdTk2c3Bic3pLVFg0ZUo3Mi00bXItYnU1amUyN1FzTTEzelFVSHJObHRlZ01pOVZyYmRDdjViUHlENGxMR0dhYl9Fc3hsT0pKY180ZzZ6NUM3WGFHZHFBVDVFRmw2eDZETC1HVXdEN1hmYWNJZw?oc=5", "source_name": "Investing.com", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical: Why The BARDA Rally Changes Nothing (NASDAQ:RCEL)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNOXNMcEZVUF9ObjdtcHZUMU1VLXZuOWFZTnBVQk13VmZJdVhMVm4wQWtTenBCTlhCa041TGdHcm9JSVZRenFfUlozNVRwYTRQSDdzNjMzUllEbE9XWWs0My1uYzlNcWhQQ0VXNmY5aVJGYmtWQXlYdlRTcVJ4V09tRkhxTmZsbENRX21rd1oxaWppQzhF?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Highlights: Merit Medical Systems (NASDAQ:MMSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQdTQyU1EtSEFYQTdZR0NhU1ZpMVdGNXhiTnlkNm9RWFRka3RfYlZBeklfTFZTRkVaOHBGNi15enNqMGlxVnJad0M5cmp3dUZzYW9Va2tOU19sMnE4V1czcFB4VWRKaVBzYnRtZ0RfVnB5TkloY3U5dW4wQllJMDJaS3BQSVNOMHlVRFQ4aDYtSV9HNTViZXc?oc=5", "source_name": "Market source", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "AVITA Medical to announce Q2 2026 financial results on August 6", "summary": "AVITA Medical has announced that it will release its second-quarter 2026 financial results after the U.S. financial markets close on August 6, 2026. The company will also host a conference call and webcast on the same day to discuss its financial performance and recent business h", "url": "https://scanx.trade/stock-market-news/companies/avita-medical-to-announce-q2-2026-financial-results-on-august-6/45616032", "source_name": "scanx.trade", "published_at": "2026-07-14T23:42:29", "published_display": "14 Jul 2026 23:42", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Schedules Q2 Results Call for Aug. 6 Webcast", "summary": "AVITA Medical (NASDAQ: RCEL, ASX: AVH) announced it will release its second quarter 2026 financial results after the close of U.S. financial markets on Thursday, August 6, 2026. The company will host a conference call and webcast at 1:30 p.m. Pacific Time the same day to discuss ", "url": "https://www.stocktitan.net/news/RCEL/avita-medical-to-announce-second-quarter-2026-financial-dewd7wgzl9j0.html", "source_name": "Stock Titan", "published_at": "2026-07-14T19:41:52", "published_display": "14 Jul 2026 19:41", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical to Announce Second Quarter 2026 Financial Results", "summary": "AVITA Medical, a therapeutic acute wound care company, announced it will release its second quarter 2026 financial results after the U.S. financial markets close on Thursday, August 6, 2026. The company will host a conference call and webcast on the same day at 1:30 p.m. Pacific ", "url": "https://ca.finance.yahoo.com/news/avita-medical-announce-second-quarter-200500002.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-14T19:41:52", "published_display": "14 Jul 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical (RCEL) Stock Sees Fair Value Lift As Analysts Back RECELL Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQWlVSdDhzMWRKWlZaRldpY1B0MEpZWlhCZTZwQTNkRlgzVlEzdEN6c2FrYldabjhhXzU2ZThta3ZYQlAxdjUxNVVoX0t0UjhsTm5nanAxZHRWdHZFVXNnZUVLbG1La0h4TFU0QnZQSWZWMjJKbDhYR3NGWHdsMkxYZWY4dm42ZFd0RGNfcy1uSHZxelJoSTZIU3JR?oc=5", "source_name": "Market source", "published_at": "2026-07-14T16:14:17+00:00", "published_display": "14 Jul 2026 16:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RCEL: Renewed Adoption Confidence Will Support Future Bullish Repricing", "summary": "Analysts have raised their consolidated price target for AVITA Medical (RCEL) to $12, citing renewed confidence in RECELL adoption, organic revenue momentum, and sufficient working capital. While bullish, some analysts acknowledge potential risks if RECELL uptake slows or executi", "url": "https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-rcel/avita-medical/ybvdyrt6-medicare-resolution-and-trauma-expansion-will-shape-future-wound-care-yb12/updates/7-analysts-have-raised-their-consolidated-price-target-for-avi", "source_name": "Simply Wall Street", "published_at": "2026-07-13T17:41:21", "published_display": "13 Jul 2026 17:41", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs \u2013 MUN:51KB", "summary": "This article provides the enterprise value to EBITDA forward for AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs, traded on the Munich Stock Exchange under the symbol MUN:51KB. The information is presented within a financial overview provided by TradingView, detaili", "url": "https://www.tradingview.com/symbols/MUN-51KB/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-12T17:09:38", "published_display": "12 Jul 2026 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical(RCEL) Stock Options Chain | Quotes & News", "summary": "This article provides details on Avita Medical's (RCEL) stock options chain, offering quotes and news related to the company's financial instruments. It serves as a resource for investors interested in RCEL's options performance and market activities.", "url": "https://www.moomoo.com/stock/RCEL-US/options-chain?chain_id=Name1K9-3FXPhg.1l07fo0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A57,%22f%22%3A%22www.moomoo.com%2Fstock%2F5026-BMS%2Fnews%22%7D", "source_name": "Moomoo", "published_at": "2026-07-04T07:09:43", "published_display": "04 Jul 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical (RCEL) Upgraded to Buy: Here's Why", "summary": "Avita Medical (RCEL) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in its earnings estimates. The Zacks rating system highlights the strong correlation between revisions in earnings estimates and near-term stock price movements, making this upgrade a positive ", "url": "https://ca.finance.yahoo.com/news/avita-medical-rcel-upgraded-buy-160003407.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-03T16:09:15", "published_display": "03 Jul 2026 16:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical Downgraded to Hold From Speculative Buy by Morgans", "summary": "Morgans has downgraded Avita Medical (ASX:AVH) from a \"Speculative Buy\" to a \"Hold\" rating. This change reflects a revised outlook from the analyst following a recent assessment of the company. Investors should consider this updated rating in their evaluation of Avita Medical's s", "url": "https://www.moomoo.com/news/post/72420522/avita-medical-downgraded-to-hold-from-speculative-buy-by-morgans?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-03T06:09:59", "published_display": "03 Jul 2026 06:09", "sentiment": "negative", "sentiment_pct": 29, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs \u2013 ASX:AVH", "summary": "This page from TradingView displays the \"Price to sales forward\" financial metric for AVITA Medical Inc Shs Chess Depository Interests, traded on the Australian Securities Exchange under the ticker ASX:AVH. The article provides a high-level overview of the company's financial dat", "url": "https://www.tradingview.com/symbols/ASX-AVH/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T02:39:41", "published_display": "30 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000 Index", "summary": "AVITA Medical, Inc. (NasdaqCM: RCEL) has been removed from the Russell 3000 Index, along with several other Russell indices including the Russell Small Cap Comp Growth Benchmark, Russell 2500 Growth Benchmark, and Russell 2000 Dynamic Index. This news was published on June 29, 20", "url": "https://www.marketscreener.com/news/avita-medical-inc-nasdaqcm-rcel-dropped-from-russell-3000-index-ce7f5fdeda8df027", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T12:47:00", "published_display": "29 Jun 2026 12:47", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Avita Medical, Inc. \u2013 NASDAQ:RCEL", "summary": "This article focuses on the enterprise value to EBITDA forward for Avita Medical, Inc. (NASDAQ: RCEL). It seems to be a financial data point from TradingView, indicating a specific valuation metric for the company. The content primarily presents navigation and various data source", "url": "https://www.tradingview.com/symbols/NASDAQ-RCEL/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T18:40:20", "published_display": "28 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical", "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AVITA Medical, Inc. (NASDAQ:RCEL) after the company's stock fell 25.8% following the announcement of its CEO's immediate departure. Investors who purchased AVITA securities are encoura", "url": "https://natlawreview.com/press-releases/bronstein-gewirtz-grossman-llc-investigating-avita-medical-inc-rcel-and", "source_name": "The National Law Review", "published_at": "2026-06-28T17:09:40", "published_display": "28 Jun 2026 17:09", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000 Growth Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOZzBzSWRwSzVoazNRMVpzZzNIWTY2Z19WTzc5ckxscUNHcGhNR2M3OVBZVE93UG5WdVpUeWh2QUJHeEF6SFZNcWhZQWs2bXhqTTU0UXlRVktmWmgxU2lpMW9hVGNxU2tvV0RHMkkwVWNqcjVkTG1GSWxGOVhEMVd6N29YdWMxOXNVT0RNRzBWTjhDcS0yQ0dVS0JRTHJIR2RGTVZkNFZqNUFXNHVWRG1MRHJ1SnlYX21oaWs0MVlWRnltMFk4U3c?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of AVITA Medical Inc \u2013 LS:A2P733", "summary": "This article provides financial information for AVITA Medical Inc (LS:A2P733) on TradingView, specifically focusing on its forward price-to-book ratio. The content is brief, indicating that the market was closed at the time of viewing and no trades were recorded for the stock.", "url": "https://www.tradingview.com/symbols/LS-A2P733/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T11:40:11", "published_display": "26 Jun 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Avita Medical, Inc. \u2013 NASDAQ:RCEL", "summary": "This article provides financial information for Avita Medical, Inc. (NASDAQ: RCEL), specifically focusing on its forward price-to-sales ratio. It presents a simple table with the period, value, change, and percentage change for this metric, noting that the data is sourced from Fa", "url": "https://www.tradingview.com/symbols/NASDAQ-RCEL/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T19:39:49", "published_display": "25 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3VmWDdGZC04R2RXUUJZTHJqVlJrdnhJYy1LaEJkcHBaWi1sWXdoWS1oLWFlVUQxdFNOQlNDdzhaTHJtMGRkX3pHc1pWbGp0bENwY1h6TlpvWVRWWmJxODh4emhGVDBFajd0VWNmUGNVcnN1SDBXRG9jZFVDa2M4MGFCVFhxbGN0ZXZqSTV2SUE1S3JjMTRnQlBiSnVmR0lv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG Maintains Avita Medical(RCEL.US) With Hold Rating", "summary": "BTIG has reiterated its Hold rating for Avita Medical (RCEL.US). This update indicates the firm's ongoing stance on the company's stock.", "url": "https://www.moomoo.com/news/post/71920696/btig-maintains-avita-medical-rcelus-with-hold-rating", "source_name": "Moomoo", "published_at": "2026-06-24T04:09:40", "published_display": "24 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting", "summary": "AVITA Medical presented new clinical data at the British Burn Association Annual Meeting, showcasing the first U.K. use of its RECELL GO system. A case series of 17 burn and reconstructive surgery patients at Stoke Mandeville Hospital demonstrated successful outcomes and improved", "url": "https://finance.yahoo.com/healthcare/articles/avita-medical-highlights-first-u-124000103.html", "source_name": "Market source", "published_at": "2026-06-22T04:09:40", "published_display": "22 Jun 2026 04:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical\u2019s burn treatment used in 17 U.K. patients", "summary": "AVITA Medical (NASDAQ: RCEL) announced the successful use of its RECELL GO system in 17 burn and reconstructive patients in the UK, with all patients discharged without complications and noted workflow benefits for the surgical teams. The findings were presented at the 2026 Briti", "url": "https://www.stocktitan.net/news/RCEL/avita-medical-highlights-first-u-k-clinical-experience-with-recell-ofglppe3u8op.html", "source_name": "Stock Titan", "published_at": "2026-06-19T00:09:03", "published_display": "19 Jun 2026 00:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Inc (RCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for AVITA Medical Inc (RCEL), detailing its regional revenue contributions. As of the latest update, the data primarily shows revenue by region, with the United States accounting for the vast majority. The article indicates that business ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rcel/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T11:09:38", "published_display": "17 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Inc (RCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides historical dividend and stock split information for AVITA Medical Inc (RCEL). It indicates that AVITA Medical Inc has not distributed any dividends over the past five years and shows no data for stock splits. The page primarily serves as a financial data por", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rcel/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T11:09:38", "published_display": "17 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Inc (RCEL) Financial Health: Profitability & Balance Sheet Analysis", "summary": "AVITA Medical Inc (RCEL) has a current financial score of 7.84, placing it 77th out of 388 in the Biotechnology & Medical Research industry, indicating weak financial status but high operating efficiency. The company reported a quarterly revenue of $19.25M, a 3.98% year-over-year", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rcel/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T10:09:38", "published_display": "17 Jun 2026 10:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Inc (RCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "AVITA Medical Inc (RCEL) has an earnings forecast score of 8.00, ranking 163rd in its industry. Analysts have set an average price target of $5.50, with a consensus \"Buy\" rating based on 5 analysts. The company's recent EPS was -$0.38 against an expectation of -$0.35, and the nex", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rcel/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T04:41:50", "published_display": "17 Jun 2026 04:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Inc (RCEL) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "AVITA Medical Inc (RCEL) has a risk assessment score of 2.77, ranking it 191 out of 388 in the Biotechnology & Medical Research industry. The company's beta value of 1.88 indicates higher volatility relative to the S&P 500. The risk assessment also details various financial metri", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-rcel/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-17T04:41:50", "published_display": "17 Jun 2026 04:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical (RCEL) CFO receives 2,000-share equity grant in Form 4", "summary": "AVITA Medical's CFO, David D. O'Toole, was granted 2,000 shares of common stock at a reference value of $3.97 per share. This compensation-related award increased his directly held stake to 152,927 shares, which includes unvested Restricted Stock Units (RSUs). The transaction was", "url": "https://www.stocktitan.net/sec-filings/RCEL/form-4-avita-medical-inc-insider-trading-activity-594ecd07e425.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:29:51", "published_display": "12 Jun 2026 20:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRWNsVUM3aGV5UmJHYUowOWtNRU11RzZSalpyampRQ3ZQTlBNV05zSHo4MTJJS0JqTV92LWV3MUdXWkRIckNNZi1aeVg1TmtKNFpoS3g5dTBXRW1BZXRMWGo1SVl2NjNaQ2NSNV90V0MtMzBEQndVclZzUUVXbi1FU0lyU0FndlAwaXNfUVpOTXBEZWQtQVpmanRoU0JjLWxlakFJSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical (RCEL) director adds 5,200 shares in open-market buy", "summary": "AVITA Medical, Inc. director Woody Joseph Fralin purchased 5,200 shares of the company's common stock at $4.00 per share on June 9, 2026, increasing his direct holdings to 107,961 shares, which include unvested Restricted Stock Units (RSUs). This open-market transaction signals i", "url": "https://www.stocktitan.net/sec-filings/RCEL/form-4-avita-medical-inc-insider-trading-activity-4cfba4622195.html", "source_name": "Stock Titan", "published_at": "2026-06-11T02:11:16", "published_display": "11 Jun 2026 02:11", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical director Woody Fralin buys $20,800 in common stock", "summary": "AVITA Medical director Woody Fralin recently purchased 5,200 shares of the company's common stock for $20,800. This transaction increases his direct holdings to 107,961 shares, including unvested Restricted Stock Units. The purchase occurs as AVITA Medical's stock, despite a rece", "url": "https://www.investing.com/news/insider-trading-news/avita-medical-director-woody-fralin-buys-20800-in-common-stock-93CH-4736452", "source_name": "Investing.com", "published_at": "2026-06-11T02:11:16", "published_display": "11 Jun 2026 02:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical director Woody Fralin buys $41,900 in stock", "summary": "AVITA Medical director Woody Joseph Fralin purchased 10,000 shares of the company's common stock for a total of $41,900 on June 9, 2026. This insider transaction increases his direct ownership to 102,761 shares. The purchase occurred as the stock is considered undervalued by Inve", "url": "https://www.investing.com/news/insider-trading-news/avita-medical-director-woody-fralin-buys-41900-in-stock-93CH-4734034", "source_name": "Investing.com", "published_at": "2026-06-10T03:09:26", "published_display": "10 Jun 2026 03:09", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Joseph Woody Acquires 10,000 Shares of AVITA Med", "summary": "Joseph Woody, a Director at AVITA Medical Inc (RCEL), purchased 10,000 shares of the company on June 9, 2026, increasing his total holdings to 102,761 shares. This transaction is part of a trend of insider buying at AVITA Medical, with 11 insider buys and no sells over the past y", "url": "https://www.gurufocus.com/news/8908798/insider-buying-joseph-woody-acquires-10000-shares-of-avita-medical-inc-rcel", "source_name": "GuruFocus", "published_at": "2026-06-09T23:09:26", "published_display": "09 Jun 2026 23:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Woody Fralin buys 10,000 AVITA Medical (RCEL) shares", "summary": "AVITA Medical, Inc. director Woody Joseph Fralin reported purchasing 10,000 shares of common stock in open-market transactions, priced at $4.18 and $4.20 per share. The total value of these purchases was $41,900. These transactions were disclosed in a Form 4 SEC filing, indicatin", "url": "https://www.stocktitan.net/sec-filings/RCEL/form-4-avita-medical-inc-insider-trading-activity-d6b83523b05b.html", "source_name": "Stock Titan", "published_at": "2026-06-09T21:09:26", "published_display": "09 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Boreham\u2019s Crucible: Avita Medical \u201cback on track\u201d \u2026 this time", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOTnd3SWhqYVRDLXZXaHNsclhsRU5pRURQV2xxbk1NdXhSM1RHNUhGSHBCR2owWHJJLVhHQ3FCX3ZSRUFSSno3S2djbTBYdG43NmNhUk9hMTFhRl9GWkh6aHlaN1RKWTlWcWMwbnNreUJsdzY4Wi1fQTEtWFdLcnZmeHFGcEFBT1Bjci1OVy1wRjlmTS1FU2c?oc=5", "source_name": "Stockhead", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQV2pTUXRCTjY5SmdHMUhoekd1YmdUMW44R1VVYVlZZzh6QzB1VDZqSzJXT1RLOWpZeE16cGVfaVU3bUFsZ0g5OUkyRlpmQjUxUGw0eDAyb3oySURyM2taYm5qeWZRSzJHNmpLT3VSV3RNS3M3X2ZldWZNRGM4My1QYnNTRVI5WHRybDhfVll4OVdJTFpZUEpNdUZtRTVHVC1ORWFpanRUZmI1bTE0?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNMTBnNnM2WGg4UWl4LXNNdUdWLVozU3ptQlRZQTk2SFFsOEZTLTVlbU5tNnhSTVRXX3RYczQ5b2hCR254bS1QYmZqV2JfdVFYTEx2U0hFeW1VREwybmRDWEE3MEpSWldySDJNTHFXbWcta2tNY0cwM0hVWld5VnVOWE1zY1VNQS1wQkIyZHN5a0dRNktDdnBvaTcyY3RKa292aThMTmNGeUpUUVU1Unhr?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical to Host Investor Webinar Briefing", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/avita-medical-host-investor-webinar-220000491.html", "source_name": "GlobeNewswire", "published_at": "2026-05-17T22:00:00+00:00", "published_display": "17 May 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Two AVITA Medical investor Q&As with CEO Cary Vance on May 20\u201321", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPeHZORXpOOXRGcTRfdnNDSXlfc2JZbEpCbnJsT2dNMzFiVHRVM3N1VWR1UXplZVBiSW1MSm1QVWt0Z3ZPSHQxRXFaYUpUd3o4RTNhTGkwbkk2UFNCWjdPTDJjbWlQTVhJOE1GLTdOcXdLb3dqdmhsbnNkdTk3clJHZ3lnc293Z2dFX1Fxc0wtN3EyXzdibEJjWQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical (RCEL) Q1 Loss Of US$0.35 Per Share Tests Profitability Optimism", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQMHFsUkVqTXg5bDN0STFlZUJ2eW9YSUl6UGNpU2NSUUdUVDIyQno0MGp5OFM3dEpWRFZHZDJMS1dtMEdhTlV5cGgzZGpEdmtyVHNuZFItbUVGQUpmWWFObDJ2elRINUdqMkpmZGFRVWljS2VNNE5oUzN1dk1KZExrd0V4c1pKb2JjMUZvRS1ScVZoWVgxRlJvNk8xWnlQNTZZWUtwVDJDMVQ4Rno1ZThWVDZnanZLRnBLMFlxUmRzNHpKNVFCQXFRTHQzanozeGlDdnBsNzF4VDZhM0Q0a3BUR9IB5gFBVV95cUxQbWdfbEVjUDJNRjJzYUxxdUo5MHlnQ1pmV0NQVGZacm96d2hPbUNjMlZMcTdwVWRtSVA3RjVDaEVRbDFDT1VOc05rVDFiVWVkNXpWejgzQ0lXQldXcFltbF9ac0dCaGhVSzBFaHFHOUZSeEo0dGtjMlpzcWdrTGVEOEctRUUtVXZQRGNQd21CMmFoUHlBOVJYdFVZb0JwR2ZJYk04aU1xSUFUY21jdXJjOFhFSGRXRjdKRVU4T3V2blYyNnl1ZEdCZTZoWTgzZFNLVjViOUlQR0M4bHZXcWpfZi1LeGc1QQ?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/a361626e-c63d-3fd5-967e-32e8a43a5c73/avita-medical%2C-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-15T12:30:00+00:00", "published_display": "15 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical, Inc. Stock 12\u2011Month Price Target Raised to $6.99, Implies 60% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNdDZIWDU5YTJtOGd6VkVMRTRtZ2Myalh4UGtlWVZhSkotWExKZWVVck1YcV9wbm9qVUxOck10VGtMb2c2YnZsZjlRdFNYcDI1T25tR3BEMXY0cGo2cVFDVXZrWkdIcXExMy1uT0hod1VmS2JmYlFScndZQTRzZ0pOOUItck0tTWxOSFZYUHpIbDI0U25MTHlQSU1zbXhwMU9Vb0ZSNUdUc0wxTEtxS0VmV3daN0VocmE1MGh5SUt5NUUwdWx2a213LVhjMVZCdWxReW9GcURkQQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 80, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Inc (AVHHL) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/avita-medical-inc-avhhl-q1-050209093.html", "source_name": "GuruFocus.com", "published_at": "2026-05-15T05:02:09+00:00", "published_display": "15 May 2026 05:02", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avita Medical Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/2b6fb4ce-847c-3ed0-9f45-8acf077beb31/avita-medical-q1-earnings.html", "source_name": "MarketBeat", "published_at": "2026-05-15T03:05:39+00:00", "published_display": "15 May 2026 03:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Q1 Loss Narrows, Revenue Rises; 2026 Revenue Guidance Reaffirmed", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/avita-medical-q1-loss-narrows-203607652.html", "source_name": "MT Newswires", "published_at": "2026-05-14T20:36:07+00:00", "published_display": "14 May 2026 20:36", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQQUR4Mk1URGlEdl9mZ2RyYzRyYXVxWFJCcUhDX05QSzNZNHIxbUxZdlJkNmxXQXhTQ3ZQa3lEVVJ4Sl9Tb2lNZmcwOF9MT3FtWU95MWxaMGNDMmQ2aXNpSm56bmIzakhhVElMTEFBYk5BRVBxeWFfUGZ0RnlSZGJ1OE1hVzdHQTN6cVhoZG9B?oc=5", "source_name": "Investing News Network", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical gains regulatory clearance for RECELL GO in Australia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPVzVtMkk2ZWNVVXhnZHFMNzJnMlRpNFd3ZkFqSFFJeEhiLUdEV2FYVGtzUFQzckVrMDVjRGtLUjJUeHNZRXQ2WFVqaTQzMEFLOTRYOElxdTk2c3Bic3pLVFg0ZUo3Mi00bXItYnU1amUyN1FzTTEzelFVSHJObHRlZ01pOVZyYmRDdjViUHlENGxMR0dhYl9Fc3hsT0pKY180ZzZ6NUM3WGFHZHFBVDVFRmw2eDZETC1HVXdEN1hmYWNJZw?oc=5", "source_name": "Investing.com", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVITA Medical: Why The BARDA Rally Changes Nothing (NASDAQ:RCEL)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNOXNMcEZVUF9ObjdtcHZUMU1VLXZuOWFZTnBVQk13VmZJdVhMVm4wQWtTenBCTlhCa041TGdHcm9JSVZRenFfUlozNVRwYTRQSDdzNjMzUllEbE9XWWs0My1uYzlNcWhQQ0VXNmY5aVJGYmtWQXlYdlRTcVJ4V09tRkhxTmZsbENRX21rd1oxaWppQzhF?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Highlights: Merit Medical Systems (NASDAQ:MMSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQdTQyU1EtSEFYQTdZR0NhU1ZpMVdGNXhiTnlkNm9RWFRka3RfYlZBeklfTFZTRkVaOHBGNi15enNqMGlxVnJad0M5cmp3dUZzYW9Va2tOU19sMnE4V1czcFB4VWRKaVBzYnRtZ0RfVnB5TkloY3U5dW4wQllJMDJaS3BQSVNOMHlVRFQ4aDYtSV9HNTViZXc?oc=5", "source_name": "Market source", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 97, "total_relevant": 68, "sentiment_summary": {"positive": 17, "negative": 7, "neutral": 44, "score": 54, "total": 68, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 20.3, "count": 35}, {"event": "earnings", "label": "Earnings", "weight": 13.75, "count": 25}, {"event": "analyst", "label": "Analyst action", "weight": 2.75, "count": 5}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 17, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 4.06, "latest_week": "2026-07-10", "one_week_move": -19.8, "four_week_move": 3.8, "twelve_week_move": -21.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.057261, "market_dynamics_buy_signal": false, "relative_strength": -20.314661, "fair_value_gap": -54.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 44.3134, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-19.8% over one week, +3.8% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 17}, {"label": "Stock Titan", "count": 6}, {"label": "TradingView", "count": 6}, {"label": "TradingKey", "count": 5}, {"label": "Moomoo", "count": 3}, {"label": "Investing.com", "count": 3}, {"label": "Yahoo! Finance Canada", "count": 2}, {"label": "StockStory", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 68}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 35}, {"label": "Earnings", "count": 25}, {"label": "Analyst action", "count": 5}, {"label": "Capital return", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "68", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-19.8% over one week, +3.8% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "AVITA Medical to announce Q2 2026 financial results on August 6"}], "updated_at": "2026-07-16T08:06:37.019837+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}